tiprankstipranks
TipRanksTop Financial ExpertsInsidersKKR Genetic Disorder L.P.

KKR Genetic Disorder L.P. Insider Profile

4 Followers
KKR Genetic Disorder L.P., Ten Percent Owner at BridgeBio Pharma, holds 25.26M shares in BridgeBio Pharma (Ticker: BBIO). Most recently, KKR Genetic Disorder L.P. Sold $5,800,000 shares of BridgeBio Pharma on Sep 17, 2024 for an estimated value of 149.35M.
tipranks
KKR Genetic Disorder L.P.

KKR Genetic Disorder L.P.
BridgeBio Pharma (BBIO)
Ten Percent Owner

Ranked #52,510 out of 99,635 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

-2.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$687M
100.00%
A breakdown of KKR Genetic Disorder L.P.'s holdings

Insider Roles

BridgeBio Pharma
(BBIO)
Ten Percent Owner
Roles that KKR Genetic Disorder L.P. holds in companies

Most Profitable Insider Trade

Stock:
BridgeBio Pharma
(BBIO)
Rating:Informative Sell
Date:Feb 17, 2021 - Feb 17, 2022
Return:+87.00%
The most profitable trade made by KKR Genetic Disorder L.P.

KKR Genetic Disorder L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BridgeBio Pharma
Sep 17, 2024
Ten Percent Owner
Informative Sell
149.35M
$686.85M
Success Rate for
BBIO
3 out of 4 profitable transactions on
BBIO
75%
Average Return for
BBIO
Average return per transaction on
BBIO
-2.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 17, 2021
Informative Sell
$208.59M
-
$60.46
+87.00%
Sep 17, 2024
Informative Sell
$149.35M
-
$25.75
+12.30%
Jun 01, 2020
Informative Sell
$79.79M
-
$33.39
-109.00%
Jul 03, 2019
Informative Buy
$45.00M
-
$17.00
+0.90%
Jul 03, 2019
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see KKR Genetic Disorder L.P.'s performance on stock

KKR Genetic Disorder L.P. insider profile FAQ

What is the percentage of profitable transactions made by KKR Genetic Disorder L.P.?
The percentage of profitable transactions made by KKR Genetic Disorder L.P. is 75%.
    What is the average return per transaction made by KKR Genetic Disorder L.P.?
    The average return per transaction made by KKR Genetic Disorder L.P. is -2.20%.
      What stocks does KKR Genetic Disorder L.P. hold?
      KKR Genetic Disorder L.P. holds: BBIO stocks.
        What was KKR Genetic Disorder L.P.’s latest transaction?
        KKR Genetic Disorder L.P. latest transaction was an Informative Sell of $149.35M.
          What was KKR Genetic Disorder L.P.'s most profitable transaction?
          KKR Genetic Disorder L.P.’s most profitable transaction was an Informative Sell of BBIO stock on February 17, 2021. The return on the trade was 87.00%.
            What is KKR Genetic Disorder L.P.'s role in BridgeBio Pharma?
            KKR Genetic Disorder L.P.'s role in BridgeBio Pharma is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.